journal article·2023-06Open access

Designing Covalent Organic Framework‐Based Light‐Driven Microswimmers toward Therapeutic Applications

Varun Sridhar, Erdost Yildiz, Andrés Rodríguez‐Camargo, Xianglong Lyu, Liang Yao, Paul Wrede, Amirreza Aghakhani, Birgul M. Akolpoglu, Filip Podjaski, Bettina V. Lotsch, Metin Sitti

Advanced Materials· Volume 35· Issue 25

Abstract

Abstract While micromachines with tailored functionalities enable therapeutic applications in biological environments, their controlled motion and targeted drug delivery in biological media require sophisticated designs for practical applications. Covalent organic frameworks (COFs), a new generation of crystalline and nanoporous polymers, offer new perspectives for light‐driven microswimmers in heterogeneous biological environments including intraocular fluids, thus setting the stage for biomedical applications such as retinal drug delivery. Two different types of COFs, uniformly spherical TABP‐PDA‐COF sub‐micrometer particles and texturally nanoporous, micrometer‐sized TpAzo‐COF particles are described and compared as light‐driven microrobots. They can be used as highly efficient visible‐light‐driven drug carriers in aqueous ionic and cellular media. Their absorption ranging down to red light enables phototaxis even in deeper and viscous biological media, while the organic nature of COFs ensures their biocompatibility. Their inherently porous structures with ≈2.6 and ≈3.4 nm pores, and large surface areas allow for targeted and efficient drug loading even for insoluble drugs, which can be released on demand. Additionally, indocyanine green (ICG) dye loading in the pores enables photoacoustic imaging, optical coherence tomography, and hyperthermia in operando conditions. This real‐time visualization of the drug‐loaded COF microswimmers enables unique insights into the action of photoactive porous drug carriers for therapeutic applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Pickering emulsions and particle stabilization · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Physical Intelligence Department Max Planck Institute for Intelligent Systems 70569 Stuttgart Germany

Nanochemistry Department Max Planck Institute for Solid State Research 70569 Stuttgart Germany

Department of Chemistry University of Stuttgart 70569 Stuttgart Germany

Institute for Biomedical Engineering ETH Zurich 8092 Zurich Switzerland

Department of Chemistry Imperial College London W12 0BZ London UK

Cluster of Excellence e‐conversion 85748 Lichtenbergstrasse 4 Garching Germany

Department of Chemistry University of Munich (LMU) 81377 Munich Germany

School of Medicine and College of Engineering Koç University 34450 Istanbul Turkey

Funding

Deutsche Forschungsgemeinschaft

References (92)

Show source-provided references
1. 10.1126/scirobotics.abi801710.1126/scirobotics.abi8017 ↗
2. 10.1002/adtp.20180006410.1002/adtp.201800064 ↗
3. Sitti M. · 2017
4. 10.1002/adma.20200746510.1002/adma.202007465 ↗
5. 10.1002/advs.20200220310.1002/advs.202002203 ↗
6. 10.1002/adma.20190676610.1002/adma.201906766 ↗
7. 10.1039/D0CS00309C10.1039/D0CS00309C ↗
8. 10.1016/j.addr.2018.09.00510.1016/j.addr.2018.09.005 ↗
9. 10.1126/scirobotics.abm142110.1126/scirobotics.abm1421 ↗
10. 10.1002/smll.20190317910.1002/smll.201903179 ↗
11. 10.1002/aisy.20200017010.1002/aisy.202000170 ↗
12. 10.1016/j.actbio.2022.05.04010.1016/j.actbio.2022.05.040 ↗
13. 10.1038/nm.293310.1038/nm.2933 ↗
14. 10.1038/s41467-020-19322-710.1038/s41467-020-19322-7 ↗
15. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
16. 10.1002/adma.20200204710.1002/adma.202002047 ↗
17. 10.1021/jacs.6b1189910.1021/jacs.6b11899 ↗
18. 10.1002/adma.20200617710.1002/adma.202006177 ↗
19. 10.1039/D1CY01124C10.1039/D1CY01124C ↗
20. 10.1073/pnas.200736211710.1073/pnas.2007362117 ↗
21. 10.1039/D0CS01027H10.1039/D0CS01027H ↗
22. 10.1002/admt.20190058310.1002/admt.201900583 ↗
23. 10.1167/iovs.13-1182510.1167/iovs.13-11825 ↗
24. 10.1126/sciadv.aat438810.1126/sciadv.aat4388 ↗
25. 10.1038/521041a10.1038/521041a ↗
26. 10.1039/C7CE02079A10.1039/C7CE02079A ↗
27. 10.1002/adma.20190656410.1002/adma.201906564 ↗
28. 10.1039/D0CS00278J10.1039/D0CS00278J ↗
29. Zhou D. · Research · 2020 · 2020
30. 10.3233/BIR-1992-295-61210.3233/BIR-1992-295-612 ↗
31. 10.1039/C9SC00289H10.1039/C9SC00289H ↗
32. 10.1021/ja075178110.1021/ja0751781 ↗
33. 10.1002/adfm.20170555310.1002/adfm.201705553 ↗
34. 10.1002/aisy.20210026610.1002/aisy.202100266 ↗
35. 10.1021/acsami.7b1839910.1021/acsami.7b18399 ↗
36. 10.1038/s41467-019-11907-110.1038/s41467-019-11907-1 ↗
37. 10.1016/j.checat.2022.06.00610.1016/j.checat.2022.06.006 ↗
38. Peter L. M. · 2016
39. 10.1038/s41467-018-08029-510.1038/s41467-018-08029-5 ↗
40. 10.1021/acsami.9b1823410.1021/acsami.9b18234 ↗
41. 10.1039/D2MH00069E10.1039/D2MH00069E ↗
42. 10.1002/adma.20170145110.1002/adma.201701451 ↗
43. 10.1002/adfm.20210246810.1002/adfm.202102468 ↗
44. 10.1002/adma.20210706110.1002/adma.202107061 ↗
45. 10.1002/adma.20160337410.1002/adma.201603374 ↗
46. 10.1038/nnano.2016.18710.1038/nnano.2016.187 ↗
47. 10.1063/1.508096710.1063/1.5080967 ↗
48. 10.1021/acs.accounts.8b0029110.1021/acs.accounts.8b00291 ↗
49. 10.1038/s41598-017-03788-510.1038/s41598-017-03788-5 ↗
50. 10.1073/pnas.220776711910.1073/pnas.2207767119 ↗
51. 10.1039/D0TB00679C10.1039/D0TB00679C ↗
52. Mehta M. · 2017
53. 10.1016/j.preteyeres.2013.04.00110.1016/j.preteyeres.2013.04.001 ↗
54. 10.1016/S0140-6736(11)61137-910.1016/S0140-6736(11)61137-9 ↗
55. 10.1039/C5PY01841B10.1039/C5PY01841B ↗
56. 10.1088/1742-6596/2190/1/01203210.1088/1742-6596/2190/1/012032 ↗
57. 10.3390/pharmaceutics1402025410.3390/pharmaceutics14020254 ↗
58. 10.3389/fphys.2013.0035410.3389/fphys.2013.00354 ↗
59. 10.3389/fmicb.2021.74783410.3389/fmicb.2021.747834 ↗
60. 10.1038/ncomms611610.1038/ncomms6116 ↗
61. 10.1016/S1350-9462(03)00035-110.1016/S1350-9462(03)00035-1 ↗
62. 10.1016/j.ajo.2011.01.04310.1016/j.ajo.2011.01.043 ↗
63. 10.1039/D1NA00059D10.1039/D1NA00059D ↗
64. 10.1021/acsnano.0c0600010.1021/acsnano.0c06000 ↗
65. 10.1002/smll.20220109810.1002/smll.202201098 ↗
66. 10.1021/acsnano.0c0553010.1021/acsnano.0c05530 ↗
67. 10.1097/IAE.000000000000351410.1097/IAE.0000000000003514 ↗
68. 10.1038/8658910.1038/86589 ↗
69. 10.1038/s41598-017-04334-z10.1038/s41598-017-04334-z ↗
70. 10.1167/iovs.17-2285010.1167/iovs.17-22850 ↗
71. 10.1002/adhm.20210107710.1002/adhm.202101077 ↗
72. 10.1016/j.preteyeres.2016.12.00110.1016/j.preteyeres.2016.12.001 ↗
73. 10.1167/iovs.15-1676610.1167/iovs.15-16766 ↗
74. 10.1001/archopht.119.10.151810.1001/archopht.119.10.1518 ↗
75. 10.1021/jacs.2c0058410.1021/jacs.2c00584 ↗
76. 10.1039/D2TA05234B10.1039/D2TA05234B ↗
77. 10.1021/jacs.0c0648510.1021/jacs.0c06485 ↗
78. 10.1038/s41570-019-0074-610.1038/s41570-019-0074-6 ↗
79. 10.1002/chem.20210113510.1002/chem.202101135 ↗
80. 10.1002/aisy.20220031110.1002/aisy.202200311 ↗
81. 10.1364/JOSAA.24.00125010.1364/JOSAA.24.001250 ↗
82. 10.1039/C4SM00621F10.1039/C4SM00621F ↗
83. 10.3390/nano1217305510.3390/nano12173055 ↗
84. 10.3389/fchem.2020.0048810.3389/fchem.2020.00488 ↗
85. 10.1038/ncomms950810.1038/ncomms9508 ↗
86. 10.1039/D0NJ04941G10.1039/D0NJ04941G ↗
87. 10.1002/anie.20191259410.1002/anie.201912594 ↗
88. 10.1039/D0SC05328G10.1039/D0SC05328G ↗
89. 10.1021/acs.chemrev.1c0038110.1021/acs.chemrev.1c00381 ↗
90. 10.1021/ja502212v10.1021/ja502212v ↗
91. 10.1007/978-1-4614-8298-710.1007/978-1-4614-8298-7 ↗
92. Mohamed S. · J. Ophthalmol. · 2017 · 2017